Abstract:
Provided is an anticancer agent which comprises an anti-PD-1 antibody or an anti-PD-L1 antibody as an active ingredient, functioning to reverse the unresponsiveness of iNKT cells in which anergy has been induced by administration with an iNKT cell ligand. The anti-PD-1 or anti-PD-L1 antibody blocks the PD-1/PD-L1-mediated signaling pathway not only to prevent the iNKT cell ligand-induced iNKT cell anergy, but also to reverse the unresponsiveness of already anergic iNKT cells to produce cytokines. In addition, the anti-PD1 or anti-PD-L1 antibody ensures the potent anti-tumor activity of iNKT cells as demonstrated by a significant reduction in the number of metastatic nodules in B16F10 melanoma metastasis models in vivo. Collectively, the anticancer agent can be very useful in the treatment of cancer, particularly metastatic cancer.
Abstract:
An apparatus and method for updating channel information in a mobile communication terminal supporting Digital Multimedia Broadcasting (DMB) are provided. The method includes sending a broadcasting information request to an Over The Air (OTA) server over a mobile communication network, receiving broadcasting information from the OTA server over the mobile communication network, and updating stored broadcasting information based on the received broadcasting information.
Abstract:
An apparatus and a method for a peripheral device control in a portable terminal are provided. In the method for the peripheral device control in the portable terminal, the method includes selectively changing a communication path between a communication modem and a storage to a communication path between a controller and the storage by controlling a switch when the communication modem is turned off, determining information necessary for the peripheral device control through the communication path between the controller and the storage and controlling the peripheral device when the information satisfies a control condition.